Study examines effects of a two-day intermittent calorie restriction diet for patients with type 2 diabetes

Bottom Line: A diet with calorie restriction two days per week was comparable to a diet with daily calorie restriction for glycemic control in patients with type 2 diabetes.

Why The Research Is Interesting: Conventional weight-loss diets with daily calorie restriction are hard to stick with over time. Intermittent calorie restriction diets can be effective for weight loss. This study examined the long-term effects of a two-day intermittent calorie restriction diet with a diet of continuous calorie restriction over 12 months for patients with type 2 diabetes.

What and When: 137 patients with type 2 diabetes were assigned to 1 of 2 diets between April 2015 and September 2017

What (Study Interventions and Outcomes): 70 patients assigned to an intermittent calorie restriction diet (500-600 calories/day) on two nonconsecutive days with their regular diet the other five days per week and 67 patients assigned to a daily calorie restriction diet (1,200-1,500 calories/day) for 12 months (interventions); change in hemoglobin A1c (primary outcome)

How (Study Design): This was a randomized noninferiority trial. This type of randomized clinical trial is designed to assess whether an intervention is "no worse" than the comparison intervention.

Authors: Peter M. Clifton, M.D., Ph.D., of the University of South Australia, Adelaide, and coauthors

Results: The average change in hemoglobin A1c after a year was comparable between the two diets.

Study Limitations: The study population had well-controlled type 2 diabetes; medication adjustments can complicate interpreting changes in hemoglobin A1c levels; and study participants had more contact with a dietitian than is usual in a clinical setting

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage